The Mini-Mental State Examination (MMSE) has become a cornerstone in the assessment of cognitive impairment since its inception. First published in 1975, it appeared as an appendix to an article authored by Marshal F. Folstein, Susan Folstein, and Paul R. McHugh in Volume 12 of the Journal of Psychiatric Research. This initial publication marked the beginning of its widespread use in clinical and research settings. Over the decades, the MMSE has proven
to be a valuable tool for screening for dementia, estimating severity, tracking progression, and documenting responses to treatment. However, its journey from an academic tool to a commercially managed product has not been without significant debate and controversy, particularly concerning its copyright and accessibility.
From Academic Appendix to Intellectual Property
When the MMSE was first published, its copyright ownership, to the extent that it contained copyrightable content, remained with its three authors. The Journal of Psychiatric Research, originally published by Pergamon Press, later saw its copyright taken over by Elsevier. This transition set the stage for future developments regarding the MMSE's intellectual property. In a significant move, the authors subsequently transferred all their intellectual property rights, including the copyright of the MMSE, to a new entity named MiniMental. This transfer was officially registered with the U.S. Copyright Office on June 8, 2000.
This shift from individual author ownership to a dedicated entity marked a turning point. In March 2001, MiniMental entered into an exclusive agreement with Psychological Assessment Resources (PAR). This agreement granted PAR the sole rights to publish, license, and manage all intellectual property rights related to the MMSE across all media and languages globally. This commercialization of the MMSE led to significant changes in its availability and use, sparking discussions about access and cost.
Copyright Enforcement and Its Impact on Research
Despite the existence of numerous free versions of the MMSE available online, PAR maintains that the official version is copyrighted and must be acquired exclusively through their channels. This assertion of copyright has generated considerable debate within the medical and research communities. At least one legal expert has publicly questioned the strength of PAR's copyright claims, suggesting potential vulnerabilities.
The enforcement of the MMSE's copyright has drawn comparisons to the phenomenon of "stealth" or "submarine" patents. This historical practice involved patent applicants waiting until an invention gained widespread popularity before allowing the patent to issue, and only then commencing enforcement. While changes in patent law have largely eliminated such applications, the comparison highlights the perceived impact of PAR's actions. The strict enforcement of the copyright has prompted researchers to actively seek and develop alternative strategies for assessing cognition, aiming to circumvent the licensing and cost issues associated with the MMSE. One such attempt, the "Sweet 16" assessment, a 16-item test developed by Tamara Fong and published in 2011, was designed to avoid these copyright concerns. However, even this alternative, which included elements like orientation and three-object recall similar to the MMSE, faced copyright assertion, leading to its removal from the internet. This ongoing situation underscores the complex interplay between intellectual property rights and the widespread clinical need for accessible diagnostic tools.

















